Auris acquisition could prompt more mega VC rounds
The J&J-Auris tie-up will yield a huge return for investors who went in big.
Congenica aims to turn data into information
Sequencing data is all well and good, but what does it mean?
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.